ArticleJournal of thoracic disease2026
Perioperative timing of surgically implanted microaxial flow pump support in high-risk coronary artery bypass grafting: a single-center Society of Thoracic Surgeons study.
Article in Journal of thoracic disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Patients with ischemic cardiomyopathy undergoing coronary artery bypass grafting (CABG) represent a high-risk population when perioperative mechanical circulatory support is required. Evidence guiding the optimal timing of surgically implanted microaxial flow pump (mAFP) support in this setting remains limited. This study aimed to evaluate outcomes according to the timing of perioperative mAFP support in high-risk CABG patients. Methods: We conducted a single-center retrospective analysis of the Society of Thoracic Surgeons Adult Cardiac Surgery Database and electronic health records from August 2007 to September 2025. Patients undergoing isolated CABG with perioperative mAFP support were categorized as preoperative, planned intraoperative, or unplanned postoperative placement. The primary comparative analysis focused on preoperative versus planned intraoperative mAFP. Outcomes included mortality, survival, and postoperative complications. Survival was analyzed using Kaplan-Meier methods and Cox proportional hazards modeling adjusted for baseline left ventricular ejection fraction. Results: Among 34 patients, 11 received preoperative mAFP, 10 planned intraoperative mAFP, and 13 unplanned postoperative mAFP. In-hospital mortality was 0% in the preoperative group, 30% in the planned intraoperative group, and 61.5% in the unplanned postoperative group. In adjusted Cox analysis comparing preoperative versus planned intraoperative mAFP, mortality did not differ significantly [hazard ratio (HR) =2.08; 95% confidence interval (CI): 0.33-13.19; P=0.44]. Patients requiring unplanned postoperative mAFP experienced the longest intensive care unit (ICU) stays, ventilation times, and highest complication rates. Conclusions: In high-risk CABG patients, preoperative mAFP support was associated with lower early mortality compared with planned intraoperative placement, although differences were not statistically significant. Patients requiring unplanned postoperative rescue support had markedly poor outcomes. These findings highlight the potential importance of early risk stratification and proactive consideration of perioperative mAFP support.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.